339067-38-8

Basic information

• Product Name: (1-(2-methoxyphenyl)-1H-1,2,3-triazol-4-yl)methanol
• Synonyms: (1-(2-methoxyphenyl)-1H-1,2,3-triazol-4-yl)methanol
• CAS NO: 339067-38-8
• Molecular Weight: 205.216
• Mol File: 339067-38-8.mol

Chemical Properties

• CAS DataBase Reference: (1-(2-methoxyphenyl)-1H-1,2,3-triazol-4-yl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (1-(2-methoxyphenyl)-1H-1,2,3-triazol-4-yl)methanol(339067-38-8)
• EPA Substance Registry System: (1-(2-methoxyphenyl)-1H-1,2,3-triazol-4-yl)methanol(339067-38-8)

Safety Data

• Hazardous Substances Data: 339067-38-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(1-(2-methoxyphenyl)-1H-1,2,3-triazol-4-yl)methanol is used as a building block for the synthesis of various biologically active molecules, including antifungal and anticancer agents. Its unique structure and properties contribute to the development of new drugs with improved therapeutic effects.
Used in Chemical Research:
In the field of chemical research, (1-(2-methoxyphenyl)-1H-1,2,3-triazol-4-yl)methanol serves as a valuable component in the synthesis of complex organic compounds and the exploration of novel chemical reactions.
Used as a Ligand in Metal-Catalyzed Reactions:
(1-(2-methoxyphenyl)-1H-1,2,3-triazol-4-yl)methanol is utilized as a ligand in metal-catalyzed reactions, enhancing the efficiency and selectivity of these processes, which is crucial for the production of fine chemicals and pharmaceuticals.
Used as a Chiral Auxiliary in Asymmetric Synthesis:
(1-(2-methoxyphenyl)-1H-1,2,3-triazol-4-yl)methanol also finds application as a chiral auxiliary in asymmetric synthesis, playing a critical role in the creation of enantioselective reactions that produce chiral molecules with specific three-dimensional configurations, important for the development of pharmaceuticals with targeted biological activity.

Upstream product

• 90-04-0 2-methoxy-phenylamine 
• 20442-97-1 2-methoxylphenyl azide 
• 107-19-7 propargyl alcohol 

Downstream Products

• 108429-56-7 1-(o-methoxyphenyl)-1H-1,2,3-triazole 
• 1233234-91-7 1-(2-methoxyphenyl)-1H-1,2,3-triazole-4-carboxylic acid 

Relevant articles and documents

Synthesis and biological evaluation of ursolic acid derivatives bearing triazole moieties as potential anti-Toxoplasma gondii agents

Ursolic acid (UA), a plant-derived compound, has many properties beneficial to health. In the present study, we synthesised three series of novel UA derivatives and evaluated their anti-Toxoplasma gondii activity both in vitro and in vivo. Most derivative

[HDBU][HSO4]-catalyzed facile synthesis of new 1,2,3-triazole-tethered 2,3-dihydroquinazolin-4[1H]-one derivatives and their DPPH radical scavenging activity

A simple and efficient protocol has been developed for the synthesis of new1,2,3-triazole-2,3-dihydroquinazolin-4[1H]-one (DHQ) conjugates(6a?j) via ultrasound-assisted, solvent-free ionic liquid [HDBU][HSO4]-catalyzed reaction in good to excellent yields. This non-conventional, ultrasound-assisted route has taken the reactions over the conventional reflux method to provide good to excellent yields of the corresponding products (6a?j) in a very short time. In addition, mild reaction conditions, tolerance to functionalized substrates, ease of product isolation, prevention of its over oxidation and reusability of catalyst [HDBU][HSO4] are some key striking features of the methodology. The newly synthesized derivatives (6a?j) were screened for antioxidant activity using 1,1-diphenyl-2-picryl hydrazyl (DPPH) assay and are found to be a potent scavenger. The compounds 6b, 6c, 6d, 6e and 6i showed significant antioxidant activity. Molecular docking studies showed significant binding affinity in the active site of myeloperoxidase (MPO) enzyme and hence scavenged by inhibition of MPO. In silico ADMET and pharmacokinetic studies of the conjugates are very promising; a cumulative body of evidence suggests their medicinal value as a potential orally active drug candidate. Graphical abstract: [Figure not available: see fulltext.]

Design, synthesis and effect of triazole derivatives against some toxic activities of Bothrops jararaca venom

According to the World Health Organization, snakebite envenoming is a neglected disease that affects around 5.4 million people worldwide each year. In Brazil, in 2019 there were 29,000 cases of accidents, with 104 deaths. The genus Bothrops was responsibl

Selective CDK4/6 inhibition of novel 1,2,3-triazole tethered acridinedione derivatives induces G1/S cell cycle transition arrest via Rb phosphorylation blockade in breast cancer models

CDK4 & CDK6 are essential regulators of initial cell cycle phases and are always considered an exciting choice for anti-cancer therapy. In the present study, we presented the structure-based rational design & synthesis of a new class of 1,2,3-triazole tet

[Et3NH][HSO4] catalyzed solvent-free synthesis of new 1,2,3-triazolidene-indolinone derivatives

A series of new 1,2,3-triazolidene-indolinone derivatives (17a-j) were designed and synthesized via [Et3NH] [HSO4] catalyzed solvent-free approach. The synthesis strongly relied on Knoevenagel condensation of 1,4-disubstituted 1,2,3-

Mesoionic Carbene Cobalt Complexes as Multipurpose Catalyst Precursors for Hydrosilylation and Dihydropyrimidinone Synthesis

Metalation of CH2OH-substituted triazolium salts with CoCl2 under basic conditions affords C,O-bidentate chelating carbene Co(III) complexes (3a, 3b), while analogous phenyl-substituted triazolium salts produce monodentate carbene Co(II) complexes (3c, 3d). The distinct substituent-induced properties of the metal centers were demonstrated by electrochemical measurements and catalytic activities in two specific processes. The complexes showed appreciable activity in the reduction of C=O bonds through hydrosilylation, with methoxybenzene-functionalized triazolylidene Co(III) complex 3a achieving a high selectivity towards aldehydes vs. ketones with turnover frequencies (TOFs) up to 200 h?1. The C,O-chelate systems were also active catalysts in the Biginelli process, a one-step three-component reaction for efficient dihydropyrimidinone synthesis. Optimization of reaction conditions provides high activity with complex 3a, reaching TOFs of 800 h?1, the highest activity known for cobalt NHC complexes to date.

Synthesis and bioevaluation of α,α’-bis(1H-1,2,3-triazol-5-ylmethylene) ketones

Abstract: Curcumin is an active component of turmeric that has poor solubility, stability and bioavailability. The monocarbonyl curcumin analogues were modified from curcumin to achieve more stable and active compounds as compared to curcumin. Therefore,

Synthesis, characterization and photodynamic activity against bladder cancer cells of novel triazole-porphyrin derivatives

Novel triazole-porphyrin derivatives (TZ-PORs) were synthesized through the Heck reaction and then incorporated into polyvinylpyrrolidone (PVP) micelles. After verifying that this incorporation did not compromise the photophysical and chemical features of

New 1,2,3-triazole-linked tetrahydrobenzo[b]pyran derivatives: Facile synthesis, biological evaluation and molecular docking study

Abstract: An efficient ultrasound-promoted one-pot three-component synthesis of a series of new 1,2,3-triazole-linked tetrahydrobenzo[b]pyran derivatives as antifungal and antioxidant agents using NaHCO3 has been described for the first time. T

Ultrasound assisted rapid synthesis, biological evaluation, and molecular docking study of new 1,2,3-triazolyl pyrano[2,3-c]pyrazoles as antifungal and antioxidant agent

In search of new generation of triazole based antifungal agents, synthesis of series of new 1,2,3-triazolyl pyrano[2,3-c]pyrazoles under ultrasonic irradiation using NaHCO3 has been reported. The bioevaluation results indicate that, the compoun